Fig. 5From: Safety of coagulation factor concentrates guided by ROTEM™-analyses in liver transplantation: results from 372 proceduresBlood loss (as estimated by volume infused via the rapid infusion system and cell salvage autotransfusion volume, respectively), tranexamic acid usage, and MELD score in survivors and nonsurvivors of liver transplantation. For statistical evaluation, the unpaired Wilcoxon test was usedBack to article page